Drug Free Solution, Inc.
DSOL · OTC
8/31/2024 | 2/28/2021 | 2/28/2014 | 11/30/2013 | |
|---|---|---|---|---|
| Market Cap | $0 | $40 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $40 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | -100% | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | – | – | – | -39.5% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | -5,862,970% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | -5,945% |
| EPS Diluted | 0 | -0 | -0.001 | -0.001 |
| % Growth | 100% | 99.6% | 8.3% | – |
| Operating Cash Flow | – | – | -$0 | -$0 |
| Capital Expenditures | – | – | $0 | -$0 |
| Free Cash Flow | – | – | -$0 | -$0 |